---
title: "VR Headset Pupillometry Detects RAPD and Pathological Anisocoria: Study Results"
id: "medrxiv-1-pupil-symmetry-and-swinging-light-test-performed-with-vr-headset-for-detection"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-pupil-symmetry-and-swinging-light-test-performed-with-vr-headset-for-detection"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1?rss=1"
published_at: "2026-09-05T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# VR Headset Pupillometry Detects RAPD and Pathological Anisocoria: Study Results
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-pupil-symmetry-and-swinging-light-test-performed-with-vr-headset-for-detection
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1?rss=1)
- **Published At:** 2026-09-05T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Purpose: The study evaluated sensitivity of **VR pupillometry** using the HP Reverb G2 Omnicept headset to detect **anisocoria** and **relative afferent pupillary defect (RAPD)** compared with routine clinical pupil exam. - Design: Prospective clinical evaluation including 29 patients in two diagnostic groups and 19 healthy controls; procedures included a **Pupil symmetry test** and a **Swinging light test** implemented in the VR headset. - Cohorts: Group I — asymmetric optic neuropathy (N=21); Group II — suspected pathological anisocoria (N=8); Controls N=19. - Detection of RAPD: Both VR pupillometry and standard exam identified RAPD in 16 of 21 Group I patients. Five Group I patients had relative afferent pupillary asymmetry (RAPA) within the control range (0.1–0.2 mm). - Correlations: RAPA/RAPD metrics correlated with inter-eye differences in visual acuity and visual field mean deviation (MD) with R=0.58 and R=0.68 respectively (p 5.8 dB inter-eye MD difference had RAPD by testing. - Anisocoria detection: In Group II, **pathological anisocoria** (>0.8 mm) was detected by VR pupillometry in all relevant cases; only 1 of 8 was detected on standard exam. - Controls: Anisocoria between 0.4–0.8 mm was seen in 37% (7/19) of controls; anisocoria was larger in the dark (mean additional 0.2 mm). - Performance summary: VR pupillometry matched conventional exam for RAPD detection and exceeded it for detecting pathological anisocoria. Longitudinal pupillary constriction data were proposed as potentially useful for diagnosis and monitoring. - Availability and ethics: Data available on request. Ethical approval and patient consent were obtained; funding sources declared. - Note: This is a medRxiv preprint not yet peer reviewed and should not guide practice without further validation.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=CTeU5oo.OnqU4MxBvWnT7XkLQdXcRvzp4AqHAnMXkB0-1788625428.3391616-1.2.1.1-yRhALHQX5gqpZKHLJYkwh_XM_omEBXQFizS27_c5oMTi1nKAdx8QW8A2Cz.kNRl8) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Pupil symmetry and Swinging Light Test Performed with VR Headset for Detection of Anisocoria and Relative Afferent Pupillary Defect Maja Strumbelj, [ View ORCID Profile](http://orcid.org/0000-0003-4136-8242)Natasa Vidovic Valentincic, [ View ORCID Profile](http://orcid.org/0000-0001-6132-4808)Ana Fakin doi: https://doi.org/10.64898/2026.09.02.26361629 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Maja Strumbelj 1 Eye Hospital, University Medical Centre Ljubljana; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Maja%2BStrumbelj%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Strumbelj%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMaja%2BStrumbelj%2B) Natasa Vidovic Valentincic 1 Eye Hospital, University Medical Centre Ljubljana; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Natasa%2BVidovic%2BValentincic%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Vidovic%20Valentincic%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANatasa%2BVidovic%2BValentincic%2B) * [ORCID record for Natasa Vidovic Valentincic](http://orcid.org/0000-0003-4136-8242 "Open in new tab") Ana Fakin 2 University Medical Centre Ljubljana * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ana%2BFakin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fakin%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAna%2BFakin%2B) * [ORCID record for Ana Fakin](http://orcid.org/0000-0001-6132-4808 "Open in new tab") * For correspondence: ana.fakin@mf.uni-lj.si * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1293554/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1293554/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1293554/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1293554/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1293554/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Purpose: Pupil examination is a routine examination of patients presenting with ophthalmological or neurological symptoms. Our purpose was to determine the sensitivity of pupillometry using HP Reverb G2 Omnicept virtual reality (VR) headset for detecting anisocoria and relative afferent pupillary defect (RAPD). Methods: Twenty-nine patients were included; Group I with asymmetric optic neuropathy (N=21) and Group II with suspected pathological anisocoria (N=8); alongside 19 controls. VR pupillometry consisted of Pupil symmetry test and Swinging light test. Pathological thresholds were established using upper limits of controls. Results were compared with routine pupil exam. Correlations with functional ophthalmological test results were analyzed. Results: RAPD was detected in 16/21 Group 1 patients using both VR pupillometry and standard exam. Remaining 5 had relative afferent pupillary asymmetry (RAPA) within the control range (0.1-0.2 mm). Significant correlation was found between RAPA/RAPD and inter-eye difference in visual acuity and visual field defect (MD) (R=0.58 and 0.68, p 5,8 dB inter-eye MD difference had RAPD. In Group II, pathological anisocoria (>0.8 mm) was detected using VR pupillometry and 1/8 on standard exam. Qualitative differences in pupillary constriction were observed. In control group anisocoria (0.4-0.8 mm) was detected in 37% (7/19); in all greater in the dark (mean 0.2 mm). Conclusion: In comparison to conventional exam VR pupillometry matched detection rate of RAPD and surpassed detection rate of pathological anisocoria. Longitudinal data on pupillary constriction characteristics could significantly contribute to patient diagnosis and monitoring in clinical studies as well as understanding physiological variability. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Republic of Slovenia National Medical Ethics Committee, decision No. 0120-644/2025-2711-3, application dated 19 December 2025, approved 23 January 2026 I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Funder Information Declared The Slovenian Research and Innovation Agency, J3-1750 Ljubljana University Medical Centre, 20220038 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.02.26362011v1 "Skin Cancer Classification Using Explainable Artificial Intelligence With an Ensemble Model and Rigorous Leakage Free Validation") Posted September 05, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/05/2026.09.02.26361629.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.02.26361629v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/05/2026.09.02.26361629.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Pupil symmetry and Swinging Light Test Performed with VR Headset for Detection of Anisocoria and Relative Afferent Pupillary Defect Maja Strumbelj, Natasa Vidovic Valentincic, Ana Fakin medRxiv 2026.09.02.26361629; doi: https://doi.org/10.64898/2026.09.02.26361629 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.02.26361629v1%26text%3DPupil%2520symmetry%2520and%2520Swinging%2520Light%2520Test%2520Performed%2520with%2520VR%2520Headset%2520for%2520Detection%2520of%2520Anisocoria%2520and%2520Relative%2520Afferent%2520Pupillary%2520Defect "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.02.26361629v1%26t%3DPupil%2520symmetry%2520and%2520Swinging%2520Light%2520Test%2520Performed%2520with%2520VR%2520Headset%2520for%2520Detection%2520of%2520Anisocoria%2520and%2520Relative%2520Afferent%2520Pupillary%2520Defect "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.02.26361629v1%26title%3DPupil%2520symmetry%2520and%2520Swinging%2520Light%2520Test%2520Performed%2520with%2520VR%2520Headset%2520for%2520Detection%2520of%2520Anisocoria%2520and%2520Relative%2520Afferent%2520Pupillary%2520Defect%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.02.26361629v1%26title%3DPupil%2520symmetry%2520and%2520Swinging%2520Light%2520Test%2520Performed%2520with%2520VR%2520Headset%2520for%2520Detection%2520of%2520Anisocoria%2520and%2520Relative%2520Afferent%2520Pupillary%2520Defect "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.02.26361629) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.02.26361629v1&count=horizontal&via=&text=Pupil%20symmetry%20and%20Swinging%20Light%20Test%20Performed%20with%20VR%20Headset%20for%20Detection%20of%20Anisocoria%20and%20Relative%20Afferent%20Pupillary%20Defect&counturl=www.medrxiv.org/content/10.64898/2026.09.02.26361629v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (615) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (897) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (327) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4778) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (476) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (410) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (645) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1617) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15857) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1196) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6999) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (728) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1059) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5002) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1429) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1743) * [Hematology](https://www.medrxiv.org/collection/hematology) (583) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1338) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16255) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1163) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (665) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (151) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (721) * [Neurology](https://www.medrxiv.org/collection/neurology) (7211) * [Nursing](https://www.medrxiv.org/collection/nursing) (365) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1074) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1234) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1002) * [Oncology](https://www.medrxiv.org/collection/oncology) (3581) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1039) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (394) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (448) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (466) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (704) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1782) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (733) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (759) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5849) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9706) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2394) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1436) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1245) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (635) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (769) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (577) * [Surgery](https://www.medrxiv.org/collection/surgery) (770) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (303) * [Urology](https://www.medrxiv.org/collection/urology) (288) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) ## Follow this preprint X You can now receive automatic notifications when
## Related Clinical Research

- [After Ultragenyx Angelman drug failure, experts say other antisense therapies still hold promise](https://medichelpline.com/clinical-feed/stat-news-1-stat-after-failure-of-angelman-syndrome-drug-experts-see-hope-in-other.md)
- [SniffCell: Cell-type-resolved somatic variant discovery from bulk long-read sequencing](https://medichelpline.com/clinical-feed/medrxiv-11-cell-type-resolved-somatic-variant-discovery-from-bulk-long-read-sequencing.md)
- [Temple-Worn Optical Wearable Shows Temporal Concordance With Transcranial Doppler During Exercise](https://medichelpline.com/clinical-feed/medrxiv-3-concordance-between-a-temple-worn-optical-wearable-and-transcranial-doppler.md)
- [Diurnal and Seasonal Variation in Brain mu-Opioid and Dopamine D2 Receptor Signaling](https://medichelpline.com/clinical-feed/biorxiv-6-diurnal-and-seasonal-regulation-of-brain-mu-opioid-and-dopamine-d2-receptor.md)
- [FDA approves Zanvastro, the first disease-modifying drug for Alexander disease](https://medichelpline.com/clinical-feed/stat-news-0-stat-ionis-wins-fda-approval-for-first-drug-for-alexander-disease-a-rare-and.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.